Mutant Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Mutant Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Assessing the Effect of DZD9008 on the Pharmacokinetics of the Cocktail Probes Representative for CYP3A4, P-gp, BCRP and OATP1B1 in Patients with EGFR or HER2 Mutant Advanced Non-small Cell Lung Cancer (WU-KONG19) [Phase 1]
Phase 1 trial update evaluating how DZD9008 influences the pharmacokinetics of cocktail probe drugs reflecting CYP3A4, P-gp, BCRP, and OATP1…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLC [Phase 2]
A single-arm Phase 2 trial evaluating the efficacy and safety of trastuzumab deruxtecan in patients with HER2-mutant non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated neratinib with and without temsirolimus in patients with HER2-activating mutations in non-small cell lung cancer; …